The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of tyrosine kinase inhibitors (TKIs) based on the ALK resistance mutations on amplicon-based liquid biopsy in ALK positive non-small cell lung cancer (NSCLC) patients (pts).
 
Laura Mezquita
No Relationships to Disclose
 
Aurélie Swalduz
Consulting or Advisory Role - Bristol-Myers Squibb; Roche
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Pfizer; Takeda
 
Cecile Jovelet
No Relationships to Disclose
 
Sandra Ortiz-Cuaran
No Relationships to Disclose
 
David Planchard
Honoraria - PeerVoice; Prime Oncology
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; MedImmune; MSD Oncology; Novartis; Pfizer; Roche
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi/Aventis (Inst); Taiho Pharmaceutical (Inst)
 
Gonzalo Recondo
No Relationships to Disclose
 
Jose Carlos Benitez
No Relationships to Disclose
 
Karen Howarth
Employment - Inivata
Stock and Other Ownership Interests - Inivata
Research Funding - Inivata
Patents, Royalties, Other Intellectual Property - Patent pending
 
Clive D. Morris
Employment - Inivata
Leadership - Inivata
Stock and Other Ownership Interests - Inivata
 
Emma Green
Employment - Inivata
Stock and Other Ownership Interests - Inivata
Travel, Accommodations, Expenses - Inivata
 
Ludovic Lacroix
No Relationships to Disclose
 
Luc Odier
No Relationships to Disclose
 
Etienne Rouleau
Honoraria - AstraZeneca; Bristol-Myers Squibb; Roche
Consulting or Advisory Role - HTG Molecular Diagnostics
Research Funding - AstraZeneca; Bristol-Myers Squibb; HTG Molecular Diagnostics; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Roche
 
Pierre Fournel
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD Oncology; Novartis; Pfizer; Takeda
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Lilly; Novartis; Pfizer; Roche
Research Funding - Astellas Pharma (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); OSI Pharmaceuticals (Inst); Peregrine Pharmaceuticals (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD Oncology; Novartis; Pfizer; Roche
 
Caroline Caramella
Consulting or Advisory Role - Bristol-Myers Squibb; Pfizer
 
Claire Tissot
No Relationships to Disclose
 
Maurice Perol
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech; Takeda
Research Funding - AstraZeneca (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
 
Luc Friboulet
No Relationships to Disclose
 
Benjamin Besse
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Biogen (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Inivata (Inst); Ipsen (Inst); Lilly (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Nektar (Inst); Onxeo (Inst); Pfizer (Inst); PharmaMar (Inst); Sanofi (Inst); Spectrum Pharmaceuticals (Inst); Takeda (Inst); Tiziana Therapeutics (Inst)
 
Pierre Saintigny
Honoraria - AstraZeneca; Bristol-Myers Squibb; Roche
Consulting or Advisory Role - HTG Molecular Diagnostics
Research Funding - AstraZeneca; Bristol-Myers Squibb; HTG Molecular Diagnostics; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Roche